|
|
|
Volumn 55, Issue 9 SUPPL. B, 1994, Pages 47-52
|
|
An overview of the mechanism of action of clozapine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL;
ALPHA 1 ADRENERGIC RECEPTOR;
AMOXAPINE;
AMPEROZIDE;
BRETAZENIL;
BROMOCRIPTINE MESILATE;
CLOZAPINE;
DIZOCILPINE;
DOPAMINE 2 RECEPTOR;
HALOPERIDOL;
LEVODOPA;
LOXAPINE;
LOXAPINE SUCCINATE;
MDL 100939;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
RITANSERIN;
SEROTONIN ANTAGONIST;
SEROTONIN RECEPTOR;
SPIPERONE;
UNCLASSIFIED DRUG;
COGNITION;
CONFERENCE PAPER;
DOPAMINE RELEASE;
DOPAMINERGIC TRANSMISSION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SEROTONIN RELEASE;
ANIMAL;
CLOZAPINE;
HUMAN;
RATS;
RECEPTORS, ADRENERGIC, ALPHA;
RECEPTORS, DOPAMINE;
RECEPTORS, SEROTONIN;
SCHIZOPHRENIA;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
|
EID: 0028114486
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (298)
|
|
References (0)
|
